Slide 1: Sustainability Update Investor Webinar
Sustainability Update Investor Webinar June 12th, 2025 Start time 9h30 EDT 15h30 CEST 14h30 BST
Slide 2: Cautionary Statements Regarding Forward-Looking Information
. Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the
Slide 3: Agenda
Agenda Opening remarks 1 Navigating Global Challenges 2 Sustainability highlights 3 Pharmaceuticals Update 4 Dr. Chitkala Kalidas Dr. Claus Runge Bill Anderson Matthias Berninger Head of Public Affairs, Chief Executive Officer & Chief Head of Public Affairs, Head of Environment, Social & Sustainabil
Slide 4: Progress and Highlights of our Sustainability Journey
Group Progress and Highlights of our Sustainability Journey Pathway recently reaffirmed by the Board of Management In 2024, we reached In 2024, we achieved 52m smallholder farmers in LMICs with 21.3% Scope 1 & 2 emissions reduction 1 our products and services1 12.7% Scope 3 emissions reduction 1 A r
Slide 5: Bayer's Sustainability Council Moving Forward
Group Bayer’s Sustainability Council Moving Forward Strategic and operational support on value-adding projects in our sustainability strategy Outcome focused multi- Ashok Gulati Facundo Etchebehere* Professor of Agricultural Co-founder of Ambition Loop, level engagement Economics at the Indian Counc
Slide 6: Pharmaceuticals: Health for All and Access to Contraception
Pharmaceuticals Division lives up to its mission "Health for All" Global Health Unit fosters access to Bayer‘s portfolio in LMICs, commits to serving 100m women with contraception Progress on Access to Contraception Top 10 Europe/ Middle East/Asia AtM position 32 million women reached in 2024 Latin
Slide 7: Building Momentum for Long-Term Growth as of 2027
Pharmaceuticals Pharmaceuticals Building Momentum for Long-Term Growth as of 2027 Global Health Unit supports Divisional Strategy, contributes to the business across product lifecycles in LMICs 2023 2024-2026 (cpa) 2027+ illustrative New Launch Assets New Launch Assets: Elinzanetant, Acoramidis Retu
Slide 8: Global Health Unit: Inclusive Growth across Portfolio
Pharmaceuticals Global Health Unit: Inclusive Growth across Portfolio Key Progress in 2024 / 2025 New launch NTDs: Emodepside (whipworm inf.) received Orphan Drug Designation by FDA assets & pipeline Up-scoring for assets with global health & LMIC opportunities in development assessment Nubeqa and K
Slide 9: Health for All through Access to Self-Care
Consumer Health Health for All through Access to Self-Care Help billions of people live healthier lives with the most trusted self-care solutions REACH MORE HEALTH THAT ELEVATE PEOPLE MATTERS INDUSTRY “Help Billions’’ “Live Healthier’’ “Trusted Self-Care’’ Prenatals Heart Clear Pain Health breathing
Slide 10: Growing Trusted Brands with Access and Sustainability
Consumer Health Growing Trusted Brands with Access and Sustainability Growing Accessible Decreasing demand solutions footprint NUTRITION EDUCATION LOW-INCOME PACKAGING: + SYSTEM CHANGE PORTFOLIO PVC FREE BLISTER 500K people educated via reach52 +78% low-income consumers -38% carbon footprint* Commun
Slide 11: 5-year framework to strengthen financial profile and unlock growth
Crop Science We put a 5-year framework in place to strengthen our financial profile, enhance resilience, and unlock our full growth potential 2030+ Expand beyond the Core Biological Biofuel Accelerating by 2027 and beyond solutions seeds … >€3.5bn Incremental net sales incl. innovation Capitalize pi
Slide 12: Driving Agricultural Solutions Through Innovation and Responsible Business Conduct
Crop Science Driving Agricultural Solutions Through Innovation and Responsible Business Conduct Our business model Our Innovations Bayer CS core platforms1 Unique pipeline of high order for farmers to S&T New enable regenerative agricultural systems. Core CP value ~500 new seeds per year3 Corn Soy O
Slide 13: Future of Agriculture: Scaling Regenerative Ag
Crop Science Future of Agriculture: We are the only company with the portfolio and innovation to scale regenerative Ag and unlock new farmer value Regen Ag market shift: From individual products To integrated systems across seasons that deliver farmer profits & resilience We benefit from shift as on
Slide 14: Questions & Answers
Questions & Answers Please specify your First Name, Last Name and Company in the "Name" field in zoom, in order to allow for a correct identification. To ask a question please click on the ‘raise your hand’ icon. When you will be called to ask your question, you first have to unmute yourself by conf